« Going Crazy For Customers | Main | Thoughtful selling »

December 04, 2006


Belstaff Jackets

For any folks invested in more and better resident contribution, that is a knock back, i believe. But strangely enough, the newest one-pager Can involve many responsibilities around consultation.

Paul Hebert

The most important comment in the post is "Sales performance, alignment with customer needs and the cost of sales is becoming more of a focus at the boardroom level."

It's about time that people performance becomes mission critical for companies. I would ammend the statement to include "all" employees - not just sales. As a professional in the performance improvement industry I have continually seen companies dismiss the effort and investment required to truly attract, engage and retain their most important point of difference in their comnpany - their people. As the economy moves from manufacturing-based to knowledge-based, the performance of a company's human capital needs to become the most important focus of the "C" level.

Until companies see their human capital as the "new factory" and treat them as well as they treat the machines that produced their products in the past they will continue to wonder why they can't compete.

I know that sounds a bit detached but only to make the point that the current and future economy will rely on how well companies maintain their production equipment - their people.

Daniel Haszard

Eli Lilly zyprexa cost me $250.00 a month supply and has up to ten times the risk of causing diabetes and severe weight gain.

Nervous investors watch Eli Lilly shares drop $2.80 post election.

My issue is Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.

So how does Zyprexa get to be the 7th largest drug sale in the world?
Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses.

The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.


Daniel Haszard

The comments to this entry are closed.

My Photo

Expert Voices

meetings industry soapbox